A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer-Reference-Cited by-同舟云学术

A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer

Published:2018-01 Issue:1 Volume:29 Page:162-169
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Criscitiello C.,Bayar M.A.,Curigliano G.,Symmans F.W.,Desmedt C.,Bonnefoi H.,Sinn B.,Pruneri G.,Vicier C.,Pierga J.Y.,Denkert C.,Loibl S.,Sotiriou C.,Michiels S.,André F.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/29/1/162/23561134/mdx691.pdf

Reference26 articles.

1. Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial;Cameron;Lancet Oncol,2013

2. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer;Liedtke;J Clin Oncol,2008

3. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis;Cortazar;Lancet,2014

4. Clinical relevance of host immunity in breast cancer: from TILs to the clinic;Savas;Nat Rev Clin Oncol,2016

5. Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis;Ignatiadis;J Clin Oncol,2012

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. On-treatment biopsies to predict response to neoadjuvant chemotherapy for breast cancer;2024-06-26

2. Enhancing Breast Cancer Neoadjuvant Therapy Prediction with Proximity Analysis of CD8 + T Cells and Immune Landscape Integration;2024-05-10

3. Tumor-infiltrating lymphocytes as a predictor of axillary and primary tumor pathological response after neoadjuvant chemotherapy in patients with breast cancer: a retrospective cohort study;Breast Cancer Research and Treatment;2024-05-04

4. B cells and the coordination of immune checkpoint inhibitor response in patients with solid tumors;Journal for ImmunoTherapy of Cancer;2024-04

5. Current and Future Trends in Neoadjuvant Immunotherapy for the Treatment of Triple-Negative Breast Cancer;Immunotherapy;2024-01-10